Concise review: Current and emerging biomarkers of nephrotoxicity

Yin, 2016, Renal drug transporters and their significance in drug-drug interactions, Acta Pharm Sin B, 6, 363, 10.1016/j.apsb.2016.07.013 Ferguson, 2008, Biomarkers of nephrotoxic acute kidney injury, Toxicology, 245, 182, 10.1016/j.tox.2007.12.024 Bellomo, 2002, Acute dialysis quality initiative II: the Vicenza conference, Curr Opin Crit care, 8, 505, 10.1097/00075198-200212000-00004 Bellomo, 2004, Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group, Crit Care, 8, R204, 10.1186/cc2872 Mehta, 2007, Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury, Crit care, 11, R31, 10.1186/cc5713 Levin, 2014, Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward, Kidney Int, 85, 49, 10.1038/ki.2013.444 Zeng, 2014, Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals, Clin J Am Soc Nephrol, 9, 12, 10.2215/CJN.02730313 Fabrizi, 2013, Acute tubular necrosis following interferon-based therapy for hepatitis C: case study with literature review, Kidney Blood Press Res, 38, 52, 10.1159/000355753 Hirschberg, 2012, Renal complications from bisphosphonate treatment, Curr Opin Support Palliat Care, 6, 342, 10.1097/SPC.0b013e328356062e Weisbord, 2005, Functional renal artery obstruction following percutaneous kidney biopsy, Nephrol Dial Transplant, 20, 1274, 10.1093/ndt/gfh828 Khan, 2015, Crystal-induced acute kidney injury due to ciprofloxacin, J Nephropathol, 4, 29 Farry, 2012, Long term renal toxicity of ifosfamide in adult patients – 5 year data, Eur J Cancer, 48, 1326, 10.1016/j.ejca.2012.03.009 Beebe, 2015, Rifampicin-induced nephrotoxicity in a tuberculosis patient, J Clin Tuberc Other Mycobact Dis, 1 Waheed, 2015, Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series, Clin Kidney J, 8, 420, 10.1093/ckj/sfv041 Rigatto, 2015, Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study, J Antimicrob Chemother, 70, 1552, 10.1093/jac/dku561 Bird, 2013, Risk of acute kidney injury associated with the use of fluoroquinolones, CMAJ, 185, E475, 10.1503/cmaj.121730 Gupta, 2011, Vancomycin nephrotoxicity: myths and facts, Neth J Med, 69, 379 Bonventre, 2010, Next-generation biomarkers for detecting kidney toxicity, Nat Biotechnol, 28, 436, 10.1038/nbt0510-436 Dieterle, 2010, Renal biomarker qualification submission: a dialog between the FDA-EMEA and predictive safety testing consortium, Nat Biotechnol, 28, 455, 10.1038/nbt.1625 Phillips, 2016, Rat urinary osteopontin and neutrophil gelatinase-associated lipocalin improve certainty of detecting drug-induced kidney injury, Toxicol Sci, 151, 214, 10.1093/toxsci/kfw038 Ichimura, 1998, Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury, J Biol Chem, 273, 4135, 10.1074/jbc.273.7.4135 Sabbisetti, 2013, Novel assays for detection of urinary KIM-1 in mouse models of kidney injury, Toxicol Sci, 131, 13, 10.1093/toxsci/kfs268 Pavkovic, 2016, Detection of drug-induced acute kidney injury in humans using urinary KIM-1, MIR-21, -200c, and -423, Toxicol Sci, 152, 205, 10.1093/toxsci/kfw077 Luo, 2014, Kim-1 and NGAL as biomarkers of nephrotoxicity induced by gentamicin in rats, Mol Cell Biochem, 397, 53, 10.1007/s11010-014-2171-7 Zubowska, 2013, Interleukin 18 as a marker of chronic nephropathy in children after anticancer treatment, Dis Markers, 35, 811, 10.1155/2013/369784 Lin, 2015, Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis, J Nephrol, 28, 7 Parikh, 2016, Application of new acute kidney injury biomarkers in human randomized controlled trials, Kidney Int, 89, 1372, 10.1016/j.kint.2016.02.027 Mishra, 2003, Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury, J Am Soc Nephrol, 14, 2534, 10.1097/01.ASN.0000088027.54400.C6 Mishra, 2004, Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity, Am J Nephrol, 24, 307, 10.1159/000078452 Gacka, 2016, The usefulness of determining neutrophil gelatinase-associated lipocalin concentration excreted in the urine in the evaluation of cyclosporine a nephrotoxicity in children with nephrotic syndrome, Dis Markers, 2016, 10.1155/2016/6872149 Nickolas, 2012, Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study, J Am Coll Cardiol, 59, 246, 10.1016/j.jacc.2011.10.854 Matsui, 2011, Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity, Am J Pathol, 178, 1021, 10.1016/j.ajpath.2010.12.002 Jablonowska, 2014, Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir, AIDS Res Hum Retroviruses, 30, 363, 10.1089/aid.2013.0070 Kashani, 2017, Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption, Clin Chem Lab Med, 10.1515/cclm-2016-0973 Bihorac, 2014, Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication, Am J Respir Crit Care Med, 189, 932, 10.1164/rccm.201401-0077OC Hoste, 2014, Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers, Nephrol Dial Transplant, 29, 2054, 10.1093/ndt/gfu292 Nayak, 2011, Transcriptional and post-translational modulation of myo-inositol oxygenase by high glucose and related pathobiological stresses, J Biol Chem, 286, 27594, 10.1074/jbc.M110.217141 Sun, 2016, Myo-inositol oxygenase overexpression accentuates generation of reactive oxygen species and exacerbates cellular injury following high glucose ambience: a new mechanism relevant to the pathogenesis of diabetic nephropathy, J Biol Chem, 291, 5688, 10.1074/jbc.M115.669952 Dutta, 2016, Beneficial effects of myo-inositol oxygenase deficiency in cisplatin-induced AKI, J Am Soc Nephrol, 28 Gaut, 2014, Development of an immunoassay for the kidney-specific protein myo-inositol oxygenase, a potential biomarker of acute kidney injury, Clin Chem, 60, 747, 10.1373/clinchem.2013.212993 Loboda, 2016, Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism, Cell Mol Life Sci, 73, 3221, 10.1007/s00018-016-2223-0 Agarwal, 1995, Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat, Kidney Int, 48, 1298, 10.1038/ki.1995.414 Zager, 2012, Plasma and urinary heme oxygenase-1 in AKI, J Am Soc Nephrol, 23, 1048, 10.1681/ASN.2011121147 Adler, 2016, A quantitative approach to screen for nephrotoxic compounds in vitro, J Am Soc Nephrol, 27, 1015, 10.1681/ASN.2015010060 Wang, 2012, Urinary microRNA-10a and microRNA-30d serve as novel, sensitive and specific biomarkers for kidney injury, PLoS One, 7, e51140, 10.1371/journal.pone.0051140 Ramachandran, 2013, Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury, Clin Chem, 59, 1742, 10.1373/clinchem.2013.210245 Weber, 2016, Development of a microphysiological model of human kidney proximal tubule function, Kidney Int, 90, 627, 10.1016/j.kint.2016.06.011